Methylprednisolone doesn't boost opioid's effect against cancer pain

07/15/2014 | PhysiciansBriefing.com

Methylprednisolone does not appear to improve the pain-relieving benefits of opioid therapy for cancer pain, according to a randomized 50-patient study reported in the Journal of Clinical Oncology. No significant differences were seen after seven days in medicine use or pain relief. Patients who received methylprednisolone did report less fatigue and better appetites.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health